The483.com

## About The483.com The compliance beat, finally readable. The 483 is the daily intelligence brief built for the people who actually do the compliance work — lawyers, scientists, regulatory officers, and the AI/data teams now caught in the same crosshairs. Skip the $300/year paywalls. Skip the 2,000-word press-release rewrites. Get the stories that move billions, told in the time it takes to finish your coffee. Built for your team **Scientist and R&D -** Clinical-trial integrity, AdComm verdicts, FDA guidance that reshapes your protocols overnight **In-house & outside counsel -** SEC enforcement, FCPA, patent wars, quitam, DOJ priorities **Regulatory & QA officers -** warning letters, 483 findings, audit patterns **AI safety & data governance leads -** how regulators are starting to treat models algorithmic decisions in healthcare and finance **Finance, BD, strategy -** deals, disclosure failures, the rules quietly rewriting the playbook **What you get** The Morning Brief — a 90-second daily read-through of what moved overnight. Delivered before market open, 7 AM ET, Mon–Fri. Six beats, one inbox — FDA, SEC, Deals, Legal, AI, Data Integrity. Primary sources only — every story traces back to an FDA letter, SEC filing, PACER docket, or 8-K. No press-release rewrites. AI-screened, human-written — algorithms read hundreds of filings; editors pick the angle, check the math, write the piece. RSS + archive — pipe into Slack, Notion, or your internal compliance dashboard. Free. No paywall. No ads. Editorial independence guaranteed.

The compliance beat, finally readable. The 483 is the daily intelligence brief built for the people who actually do the compliance work — lawyers, scientists, regulatory officers, and the AI/data teams now caught in the same crosshairs. Skip the $300/year paywalls. Skip the 2,000-word press-release rewrites. Get the stories that move billions, told in the time it takes to finish your coffee. Built for your team **Scientist and R&D -** Clinical-trial integrity, AdComm verdicts, FDA guidance that reshapes your protocols overnight **In-house & outside counsel -** SEC enforcement, FCPA, patent wars, quitam, DOJ priorities **Regulatory & QA officers -** warning letters, 483 findings, audit patterns **AI safety & data governance leads -** how regulators are starting to treat models algorithmic decisions in healthcare and finance **Finance, BD, strategy -** deals, disclosure failures, the rules quietly rewriting the playbook **What you get** The Morning Brief — a 90-second daily read-through of what moved overnight. Delivered before market open, 7 AM ET, Mon–Fri. Six beats, one inbox — FDA, SEC, Deals, Legal, AI, Data Integrity. Primary sources only — every story traces back to an FDA letter, SEC filing, PACER docket, or 8-K. No press-release rewrites. AI-screened, human-written — algorithms read hundreds of filings; editors pick the angle, check the math, write the piece. RSS + archive — pipe into Slack, Notion, or your internal compliance dashboard. Free. No paywall. No ads. Editorial independence guaranteed.